Dr. sc. Ruža Frkanec, Development of NOD agonists and their novel formulations as vaccine adjuvants, Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Croatia; https://www.researchgate.net/profile/Ruza-Frkanec
Prof. Dr. Emanuela Corsini, Characterization of immunomodulatory properties of NOD modulators, Dipartimento di Scienze Farmacologiche e Biomoleculari, Università degli studi di Milano, Milano, Italy; https://www.researchgate.net/profile/Emanuela-Corsini
Assist. Prof. Bram Slütter, In vitro investigation of adjuvant potential of compounds, Leiden University, The Netherlands; https://www.universiteitleiden.nl/en/staffmembers/bram-slutter#tab-1
Prof. Dr. Stéphane Paul, Characterization of adjuvant properties of NOD2 agonists, Universite Jean Monnet, Saint-Étienne, France; https://www.researchgate.net/profile/Stephane-Paul
Prof. Dr. Bernard Verrier, In vivo characterization of adjuvant properties of NOD2 agonists, CNRS and ADJUVATIS, Lyon, France; https://lbti.ibcp.fr/?page_id=2012
Prof. Dr. Gerrit Borchard, Formulation and in vivo investigation of NOD2 agonists as vaccine adjuvants, School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland; https://ispso.unige.ch/biopharmaceutical/group-members.php
Prof. Dr. Catherine Leimkuhler Grimes, Characterization of binding properties of NOD2 ligands, Dept of Chemistry and Biochemistry, University of Delaware, Newark, Delaware, USA; https://sites.udel.edu/grimesgroup/
Prof. Dr. Sudax Murdan, In vivo characterization of adjuvant properties of NOD2 agonists, UCL School of Pharmacy, UK; https://www.ucl.ac.uk/pharmacy/people/dr-sudaxshina-murdan
Assoc. Prof. Dr. Reza M. Khorooshi, In vivo evaluation of conjugated NOD2/TLR7 agonists and NOD2 agonists as anti-inflammatories, Neurobiology Research Unit, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; https://portal.findresearcher.sdu.dk/en/persons/rkhorooshi